Platform PerformancePlatform improvements demonstrate materially improved sequencing performance with significantly more alignments per well, longer reads, and higher signal-to-noise ratio, which could boost accuracy and appeal to research customers.
Post-translational Modification Detection And Market ExpansionSingle-molecule PTM detection and improved methods offer direct counting for quantification, simplified workflows with universal reagents, and precise modification-site identification, potentially opening opportunities in drug development, clinical labs, agriculture, and defense.
Scalability And Consumable DesignProteus shifts imaging complexity to the instrument using a KinetIQ Array consumable with tens of millions of wells per device and a roadmap to scale to billions, enabling higher throughput and lower per-sample costs that expand addressable markets.